Chemomab Therapeutics Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 05/15/2025 | 1.74 M | $1.90 M | 0.00% | 0.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 05/15/2025 | 900.43 K | $981.47 K | -25.86% | 0.28% |
| YELIN LAPIDOT HOLDINGS MANAGEMENT LTD. | 04/28/2025 | 578.29 K | $630.34 K | -22.29% | 0.18% |
| IKARIAN CAPITAL, LLC | 05/15/2025 | 213.05 K | $232.23 K | 0.00% | 0.07% |
| MORGAN STANLEY | 05/15/2025 | 117.16 K | $127.70 K | 12.22% | 0.04% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 05/05/2025 | 31.24 K | $34.05 K | 0.00% | 0.01% |
| VIRTU FINANCIAL LLC | 05/12/2025 | 30.80 K | $34.00 K | 113.24% | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2025 | 26.19 K | $28.55 K | 0.00% | 0.01% |
| RHUMBLINE ADVISERS | 05/29/2025 | 23.85 K | $25.99 K | 0.17% | 0.01% |
| TWO SIGMA SECURITIES, LLC | 05/15/2025 | 22.10 K | $24.09 K | 100.00% | 0.01% |
| XTX TOPCO LTD | 05/08/2025 | 13.27 K | $14.47 K | -46.75% | 0.00% |
| GAMMA INVESTING LLC | 04/15/2025 | 11.03 K | $12.02 K | 116.28% | 0.00% |
| WETZEL INVESTMENT ADVISORS, INC. | 04/22/2025 | 11.00 K | $11.99 K | 10.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 10.50 K | $11.45 K | 61.54% | 0.00% |
| UBS GROUP AG | 05/13/2025 | 883 | $962 | 82.06% | 0.00% |
| MOSER WEALTH ADVISORS, LLC | 04/22/2025 | 500 | $545 | 0.00% | 0.00% |
| 05/02/2025 | 104 | $113 | 4.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Chemomab Therapeutics Ltd. institutional Ownership - FAQ's
During the previous two years, 18 institutional investors and hedge funds held shares of Chemomab Therapeutics Ltd.. The most heavily invested institutionals were:
ORBIMED ADVISORS LLC: 1.74 M
SPHERA FUNDS MANAGEMENT LTD.: 900,428
Yelin Lapidot Holdings Management Ltd.: 578,291
Ikarian Capital, LLC: 213,052
MORGAN STANLEY: 117,160
KESTRA PRIVATE WEALTH SERVICES, LLC: 31,241
1.15% of Chemomab Therapeutics Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 3.75 M shares in the last 24 months. This purchase volume represents approximately $4.24 M in transactions.